Deregulation of protein phosphatase 2A and hyperphosphorylation of τ protein following onset of diabetes in NOD mice

Diabetes

Volumn 62, Issue 2, 2013, Pages 609-617

  Papon, Marie Amélie ^a   El Khoury, Noura B ^a,b   Marcouiller, François ^a,b   Julien, Carl ^a,b   Morin, Françoise ^a   Bretteville, Alexis ^a,b   Petry, Franck R ^a,b   Gaudreau, Simon ^c   Amrani, Abdelaziz ^c   Mathews, Paul M ^d,e   Hébert, Sébastien S ^a,b   Planel, Emmanuel ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIN DEPENDENT KINASE 5; EPITOPE; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN C JUN; PROTEIN KINASE B; TAU PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOINSULINEMIA; INDUCED HYPOTHERMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN CHEMISTRY; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; HYPOTHERMIA; MICE; MICE, INBRED NOD; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN PHOSPHATASE 2; TAU PROTEINS;

EID: 84873035509     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0187     Document Type: Article

References (50)

1. Alonso AC, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K. Hyper-phosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 2001;98:6923-6928
2. Bretteville A, Planel E. Tau aggregates: toxic, inert, or protective species? J Alzheimers Dis 2008;14:431-436
3. Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004;3:169-178
4. Frölich L, Blum-Degen D, Riederer P, Hoyer S. A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann N Y Acad Sci 1999;893:290-293
5. Leibson CL, Rocca WA, Hanson VA, et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 1997;145:301-308
6. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999;53:1937-1942
7. Lesort M, Jope RS, Johnson GV. Insulin transiently increases tau phos-phorylation: involvement of glycogen synthase kinase-3beta and Fyn ty-rosine kinase. J Neurochem 1999;72:576-584
8. Schechter R, Beju D, Miller KE. The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. Biochem Biophys Res Commun 2005;334:979-986
9. Schubert M, Gautam D, Surjo D, et al. Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 2004;101:3100-3105
10. Planel E, Tatebayashi Y, Miyasaka T, et al. Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci 2007;27:13635-13648
11. Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, Jope RS. Tau is hyper-phosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes 2006;55:3320-3325
12. Jolivalt CG, Lee CA, Beiswenger KK, et al. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. J Neurosci Res 2008;86:3265-3274
13. Kim B, Backus C, Oh S, Hayes JM, Feldman EL. Increased tau phosphor-ylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 2009;150:5294-5301
14. Qu Z, Jiao Z, Sun X, Zhao Y, Ren J, Xu G. Effects of streptozotocin- induced diabetes on tau phosphorylation in the rat brain. Brain Res 2011;1383:300-306
15. Ke YD, Delerue F, Gladbach A, Götz J, Ittner LM. Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PLoS ONE 2009;4:e7917
16. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980;29: 1-13
17. Amrani A, Durant S, Throsby M, Coulaud J, Dardenne M, Homo-Delarche F. Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage. Endocrinology 1998;139:1115-1124
18. Leiter EH. The NOD mouse: a model for insulin-dependent diabetes mel-litus. Curr Protoc Immunol 2001;Chapter 15:Unit 15.19
19. Planel E, Richter KE, Nolan CE, et al. Anesthesia leads to tau hyper-phosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 2007;27:3090-3097
20. Planel E, Yasutake K, Fujita SC, Ishiguro K. Inhibition of protein phospha-tase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphoryla- tion in the hippocampus of starved mouse. J Biol Chem 2001;276:34298-34306
21. Planel E, Miyasaka T, Launey T, et al. Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J Neurosci 2004;24:2401-2411
22. Olivieri A, De Angelis S, Dionisi S, et al. Serum transforming growth factor b1 during diabetes development in non-obese diabetic mice and humans. Clin Exp Immunol 2010;162:407-414
23. Planel E, Sun X, Takashima A. Role of GSK-3 beta in Alzheimer's disease pathology. Drug Dev Res 2002;56:491-510
24. Ksiezak-Reding H, Pyo HK, Feinstein B, Pasinetti GM. Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro. Bio-chim Biophys Acta 2003;1639:159-168
25. Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem 1989;58:453-508
26. Tian Q, Wang J. Role of serine/threonine protein phosphatase in Alzheimer's disease. Neurosignals 2002;11:262-269
27. Price NE, Wadzinski B, Mumby MC. An anchoring factor targets protein phosphatase 2A to brain microtubules. Brain Res Mol Brain Res 1999;73: 68-77
28. Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001;353:417-439
29. Su JH, Cummings BJ, Cotman CW. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport 1994;5:2358-2362
30. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994;87:554-567
31. Gasparini L, Netzer WJ, Greengard P, Xu H. Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol Sci 2002;23:288-293
32. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992;51:285-322
33. Neil HA, Dawson JA, Baker JE. Risk of hypothermia in elderly patients with diabetes. Br Med J (Clin Res Ed) 1986;293:416-418
34. Kilgour RD, Williams PA. Effects of diabetes and food deprivation on shivering activity during progressive hypothermia in the rat. Comp Bio-chem Physiol A Physiol 1996;114:159-165
35. Schnedl WJ, Ferber S, Johnson JH, Newgard CB. STZ transport and cy-totoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 1994;43:1326-1333
36. Grünblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S. Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 2007;101:757-770
37. Augustinack JC, Schneider A, Mandelkow E-M, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 2002;103:26-35
38. Gong CX, Iqbal K. Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. Curr Med Chem 2008;15:2321-2328
39. Drewes G, Trinczek B, Illenberger S, et al. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262. J Biol Chem 1995;270:7679-7688
40. Goedert M, Jakes R, Crowther RA, et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J 1994;301:871-877
41. Li ZG, Zhang W, Sima AA. Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 2007;56:1817-1824
42. Baharians Z, Schönthal AH. Autoregulation of protein phosphatase type 2A expression. J Biol Chem 1998;273:19019-19024
43. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Contributions of protein phos-phatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphoryla-tion. Eur J Neurosci 2005;22:1942-1950
44. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol 2011;225:54-62
45. Plaschke K, Kopitz J, Siegelin M, et al. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimerlike changes in Tg2576 AbetaPP-overexpressing mice. J Alzheimers Dis 2010;19:691-704
46. Clodfelder-Miller B, De Sarno P, Zmijewska AA, Song L, Jope RS. Physiological and pathological changes in glucose regulate brain Akt and gly-cogen synthase kinase-3. J Biol Chem 2005;280:39723-39731
47. Andjelković M, Jakubowicz T, Cron P, Ming XF, Han JW, Hemmings BA. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc Natl Acad Sci USA 1996;93:5699-5704
48. Sims-Robinson C, Kim B, Rosko A, Feldman EL. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 2010;6:551-559
49. Festa A, Williams K, D'Agostino R Jr, Wagenknecht LE, Haffner SM. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 2006;55:1114-1120
50. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 2004;88:787-835